Lupus and Fluorescent Light: Energy Saver CFL Bulbs Emit Ultraviolet light
San Jose Care Resource Guide: In an politically correct era when women are sometimes asked not to wear perfume to an event, because of concerns of allergic and other reactions, there is a very real dilemma.
San Jose Care Resource Guide: Here is a link to a story by a Lupus patient published in the spokesman.In a Nutshell: lupus patients can react negatively to the Ultra Violet (UV) light that is generated by Compact Fluorescent Bulbs. and those bulbs are becoming the norm…
San Jose Care Resource Guide: This is comfirmed by this FDA link, see the paragraph: ”..How close can we safely get to an operating CFL?..” This FDA note is actually well done with some numbers to work with. Not all CFL emit the same UV amounts some are safer…
Read on the FDA note: ”… As a precaution, it is recommended that these types [single envelop] of CFLs not be used at distances closer than 1 foot, for more than one hour per day….
Share on FacebookCategories: Drugs and Devices Safety, FDA warnings, Health Advocacy, Lupus Tags: CFL, FDA, Fluorescent Light Bulbs, Lupus, San Jose Care Resource Guide, SJCRG, Ultraviolet light
Comments on “FDA clears Cymbalta to treat chronic musculoskeletal pain”
SJCRG: Good news, more treatment options for chronic musculoskeletal pain! Here is the link to the FDA press release. “..Cymbalta was first used to treat major depressive disorder in 2004..”
SJCRG: Very interesting is the FDA’s philosophy for drug approval for serious illnesses:
Quoting: “..While these serious side effects have been associated with the use of Cymbalta, they have occurred in less than 1% of treated patients. There are a finite number of drugs available for the treatment of chronic musculoskeletal pain, all of which are associated with rare, serious side effects. There are patients in whom none of the available treatments are effective. ….
So let us do the math: According to the US Govn’t “..An estimated 1.5 million adults had rheumatoid arthritis in 2007….”
…so 15,000 patients are expected to come down with serious side effects.
But “..Since its initial approval, about 30 million patients in the United States have used Cymbalta..[for other conditions]..” Let us do the math now for that larger population: 1% of 30 million= 300,000 patients with serious side effects! half of the Multiple sclerosis popultation in the US!
Please do a careful risk/reward analysis with your doctor if you need Cymbalta, or any of these potent drugs….
Cymbalta is no free ride…
Share on FacebookCategories: Auto-Immune Diseases, Back Pain, Depression, Drugs and Devices Safety, Musculoskeletal, Pain, musculoskeletal Tags: careresourceguide, chronic, Cymbalta, FDA, musculoskeletal, pain, San Jose Care Resource Guide, SJCRG
Recall of Alaris medication pumps classified as most serious type (Reuters,FDA)
CareResourceGuide: These are medication pumps, and people are not on medication infusion pumps unless they really need it. are the Reuters and FDA recall links with details on the recall.
Quoting the FDA:
“…could result in serious adverse health consequences or death….”
Share on Facebook
Categories: Drugs and Devices Safety Tags: Alaris, Care Resource Guide, careresourceguide, FDA, medication pumps, most serious, Recall, Reuters

